| Product Code: ETC9582278 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Switzerland import trend for non-alcoholic steatohepatitis (NASH) biomarkers saw a decline with a growth rate of -11.3% from 2023 to 2024. The compound annual growth rate (CAGR) for 2020-2024 was -18.11%. This negative trend could be attributed to shifting healthcare priorities or regulatory changes impacting market dynamics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Switzerland Country Macro Economic Indicators |
3.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Switzerland |
4.2.2 Growing awareness about the importance of early NASH detection |
4.2.3 Rising demand for non-invasive diagnostic tools for liver diseases |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker approval |
4.3.2 Limited reimbursement policies for NASH biomarker testing |
4.3.3 High cost associated with biomarker development and commercialization |
5 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F |
6.1.4 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F |
6.1.5 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F |
6.1.6 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.4 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of clinical trials using NASH biomarkers |
8.2 Adoption rate of NASH biomarker testing by healthcare providers |
8.3 Research and development investment in NASH biomarkers |
8.4 Patient adherence to recommended NASH biomarker testing protocols |
8.5 Number of partnerships and collaborations in the NASH biomarkers market |
9 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Switzerland Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |